Microglia become hypofunctional and release metalloproteases and tau seeds when phagocytosing live neurons with P301S tau aggregates
Patients with established cardiovascular disease including previous myocardial infarction, stroke, or peripheral arterial diseaseare particularly suitable candidates, given the proven cardiovascular benefits of both drug classes
Seek immediate medical attention if you experience severe persistent abdominal pain (especially if radiating to your back), persistent vomiting, inability to keep fluids down, dark urine, dizziness, fainting, fever, or yellowing of the skin or eyes
Both compounds are potent antioxidants by themselves, but when combined, they provide a biological feedback loop that increases each one's potency
In the SUSTAIN program, 1.4% of patients treated with semaglutide developed a gallbladder event, mainly cholelithiasis
First and foremost, patients on GLP-1 medications need to be at or near their goal weight before considering surgical options